Monique Duckworth Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 22368 S. Sixth, S. Dos Palos, CA 93665 Phone: 559-268-1466 Fax: 559-258-1302 |
Michelle Ethridge Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 22368 S. Sixth, S. Dos Palos, CA 93665 Phone: 559-268-1466 Fax: 559-268-1302 |
Steve Meyers Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 22368 S. Sixth, S. Dos Palos, CA 93665 Phone: 559-268-1466 Fax: 559-268-1302 |
Crystal Joyce Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 22368 S. Sixth, S. Dos Palos, CA 93665 Phone: 558-268-1466 Fax: 559-268-1302 |
News Archive
SFJ Pharma Ltd. II announced today that it has entered into a collaborative development agreement with Pfizer Inc. to conduct a Phase 3 clinical trial in Asia of Pfizer's investigational agent axitinib for the adjuvant treatment of patients at high risk of recurrent renal cell carcinoma (RCC) following nephrectomy.
A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.
Melanomas caused by sun exposure have been matched with targeted treatments and immunotherapies, in many cases dramatically extending patients' lives. However, there are other kinds of melanoma not related to sun exposure and because they are caused by different genetic changes, they are not susceptible to the same targeted treatments.
Although assigning household chores is considered an essential component of child-rearing, it turns out they might not help improve children's self-control, a coveted personality trait that allows people to suppress inappropriate impulses, focus their attention and perform an action when there is strong tendency to avoid it.
NIDEK CO. LTD., a global leader in the design, manufacturing, and distribution of ophthalmic, optometric, and lens edging equipment, is pleased to announce the launch of the YLC-500 Vixi Yellow Scan Laser Photocoagulator / YLC-500 Yellow Laser Photocoagulator.
› Verified 2 days ago